Drugmakers now need to get government approval in France before advertising their products to health professionals and the general public, thanks to a decree that took effect May 9. The change from a content verification system to the more stringent controls is part of a broader overhaul aimed at strengthening France’s oversight under the newly organized National Agency for the Safety of Medicines and Health Products.
International Pharmaceutical Regulatory Monitor